In the cell-mixing experiments, including AKTi, we found MSC.sTRAIL gave rise to increased apoptosis in prostate cancer cells, while MSC.FL-TRAIL exerted only marginal effects (Figure 6d). Here, TNFSF10 is linked to prostate cancer.